Personal information

Websites & social links

LinkedIn

Activities

Collapse all

Employment (1)

Northwestern University: Evanston, Illinois, US

2021-08-27 to 2026-05-31 | Graduate Student (Chemical and Biological Engineering)
Employment
Source: Self-asserted source
Kevin Vasquez

Education and qualifications (2)

The University of Texas at Austin: Austin, Texas, US

2013-09-01 to 2019-05-25 | Graduate Student (Chemical Engineering)
Education
Source: Self-asserted source
Kevin Vasquez

Cornell University: Ithaca, New York, US

2009-08-27 to 2013-05-29 | Undergraduate Student (Chemical and Biomolecular Engineering)
Education
Source: Self-asserted source
Kevin Vasquez

Works (7)

Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples

Blood
2023-08-03 | Journal article
DOI: 10.1182/blood.2022016600
Contributors: Jasneet Kaur Khalsa; Justin Cha; Filippo Utro; Aishath Naeem; Ishwarya Murali; Yanan Kuang; Kevin Vasquez; Liang Li; Svitlana Tyekucheva; Stacey M. Fernandes et al.
Source: check_circle
Crossref

Abstract 3960: BCL-2 G101V mutations develop in one-third of patients on continuous venetoclax

Cancer Research
2022-06-15 | Conference poster
DOI: 10.1158/1538-7445.am2022-3960
Part of ISSN: 1538-7445
Contributors: Yanan Kuang; Stacey M. Fernandes; Rayan Fardoun; Kevin Vasquez; Abhishek Mogili; Cloud P. Paweletz; Jennifer R. Brown
Source: Self-asserted source
Kevin Vasquez

Abstract 1097: Mechanisms of primary and acquired resistance to venetoclax in chronic lymphocytic leukemia (CLL)

Cancer Research
2021-07-01 | Conference poster
DOI: 10.1158/1538-7445.am2021-1097
Part of ISSN: 0008-5472
Part of ISSN: 1538-7445
Contributors: Ishwarya Murali; Justin Cha; Ignaty Leshchiner; Yanan Kuang; Kevin Vasquez; Jasneet Khalsa; Stacey M. Fernandes; Filippo Utro; Kahn Rhrissorrakrai; Chaya Levovitz et al.
Source: Self-asserted source
Kevin Vasquez

Concurrent osimertinib plus gefitinib for first-line treatment of EGFR-mutated non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology
2020-05-20 | Journal article
DOI: 10.1200/jco.2020.38.15_suppl.9507
Part of ISSN: 0732-183X
Part of ISSN: 1527-7755
Contributors: Julia K Rotow; Daniel Botelho Costa; Cloud P. Paweletz; Mark M. Awad; Paul Marcoux; Deepa Rangachari; David Allen Barbie; Jacob Sands; Michael L. Cheng; Bruce E. Johnson et al.
Source: Self-asserted source
Kevin Vasquez

Codon Selection Affects Recruitment of Ribosome-Associating Factors during Translation

ACS Synthetic Biology
2020-02-21 | Journal article
DOI: 10.1021/acssynbio.9b00344
Part of ISSN: 2161-5063
Part of ISSN: 2161-5063
Contributors: Alejandra M. Rojano-Nisimura; Katie Haning; Justin Janovsky; Kevin A. Vasquez; Jeffrey P. Thompson; Lydia Contreras
Source: Self-asserted source
Kevin Vasquez

Slowing Translation between Protein Domains by Increasing Affinity between mRNAs and the Ribosomal Anti-Shine–Dalgarno Sequence Improves Solubility

ACS Synthetic Biology
2016-02-19 | Journal article
DOI: 10.1021/acssynbio.5b00193
Part of ISSN: 2161-5063
Part of ISSN: 2161-5063
Contributors: Kevin A. Vasquez; Taylor A. Hatridge; Nicholas C. Curtis; Lydia M. Contreras
Source: Self-asserted source
Kevin Vasquez

Influenza Virus-Membrane Fusion Triggered by Proton Uncaging for Single Particle Studies of Fusion Kinetics

Analytical Chemistry
2012-10-16 | Journal article
DOI: 10.1021/ac3006473
Part of ISSN: 0003-2700
Part of ISSN: 1520-6882
Contributors: Deirdre A. Costello; Donald W. Lee; Jennifer Drewes; Kevin A. Vasquez; Kassandra Kisler; Ulrich Wiesner; Lois Pollack; Gary R. Whittaker; Susan Daniel
Source: Self-asserted source
Kevin Vasquez
How many people are using ORCID?